“However, considering Pine Labs’ market leadership, expanding addressable market, and continued focus on high-margin, technology-driven solutions, we recommend that only risk-taking investors should ‘HOLD’ the Pine Labs IPO with a long-term investment perspective. New investors are advised to wait and watch for any post-listing correction as a potential entry opportunity,” he said.
Pine Labs IPO, which was a combination of a fresh issue of equity shares worth ₹2,080 crore and an offer for sale of shares aggregating to ₹1,819.91 crore, was subscribed 2.48 times. The Noida-based company had fixed the price band at ₹210–₹221 per share, valuing the company at around ₹25,377 crore at the upper end of the issue price.
The public issue, which opened for bidding between November 7–11, was subscribed 1.27 times in the retail category, 3.97 times in qualified institutional buyers (QIBs), and 0.30 times in the non-institutional investors (NIIs) category.
Pine Labs IPO bidding started on November 7, 2025, and ended on November 11, 2025. The allotment for the Pine Labs IPO was finalized on November 12, 2025. Pine Labs IPO will list on the BSE and NSE on November 14, 2025.
Founded in 1998, Pine Labs is one of India’s leading merchant commerce platforms, offering payment solutions, merchant financing, and other fintech services to retailers and enterprises. Over the years, it has expanded into Southeast Asia and the Middle East, with key investors including Sequoia Capital, Temasek Holdings, and Mastercard.